Eli Lilly and Company (LLY) New York Stock Exchange
117.092.412.10%
CloseJanuary 15, 2019

News: updated – 16-Jan 01:32


FDA to beef up cell and gene therapy staff15-Jan 01:17(SeekingAlpha)

Citing the 800 active INDs for cell therapy and gene therapy candidates and the expectation that it will be receiving more that 200 INDs each year by 2020, FDA Commission Scott Gottlieb, M.D., outlines the agency’s initiatives to support timely review and to enable the approval of 10 – 20 …

FDA Commish touts advances/successes15-Jan 12:45(SeekingAlpha)

In a stream of tweets , FDA Commissioner Scott Gottlieb, M.D. details a number of accomplishments and advances by the agency. Highlights: More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla World Healthcare Fund, Healthcare stocks …

Merger Arbitrage Mondays – January 14, 201814-Jan 07:56(SeekingAlpha)

Merger activity increased last week with three new deals announced and seven pending deals closing. Deal Statistics: New Deals: The acquisition of Luxoft Holding (LXFT) by DXC Technology Company (DXC) for $2 billion or $59.00 per share in cash. The acquisition of Loxo Oncolo…